Valuation (57%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -42.20 | 4.84 |
| PEG Ratio (TTM) | 0.19 | -1.06 |
| P/S Ratio (TTM) | 14.05 | 52.76 |
| P/B Ratio (TTM) | 0.90 | 0.95 |
| P/FCF Ratio (TTM) | 17.98 | 18.70 |
| Price to 5YR AVG Earnings Ratio | -72.34 | 26.66 |
| Price to 5YR AVG FCF Ratio | 20.65 | 29.36 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -1.43% | 1.17% |
| ROE (TTM) | -2.26% | 5.34% |
| Net Profit Margin (TTM) | -33.28% | 28.64% |
| ROIC 5YR AVG | -0.01% | 7.80% |
Growth (72%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -20.16% | 771.52% | 406.98% |
| Revenue | 12.29% | 881.05% | 478.22% |
| Net Income | -20.85% | 774.79% | 408.68% |
| Cash Flow | 7.56% | 9.86% | -0.80% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.05 | 1.63 |
| Quick Ratio (TTM) | 0.05 | 1.59 |
| D/E Ratio (TTM) | 0.47 | 0.72 |
| Interest Coverage (TTM) | -4.18 | 20.09 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 0.57 | 7.53 |
| LTL to 5YR AVG FCF | N/A | 9.38 |
| Shares Outstanding Growth 5YR AVG | 0.38% | -1.05% |